Cefipark S 500mg/250mg Injection
Marketer
Park Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefipark S 500mg/250mg Injection
Cefipark S 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; missed doses should be avoided. Complete the prescribed treatment, even with symptom improvement, as premature cessation might compromise effectiveness. Typical mild reactions include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects promptly to your doctor. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor the medicine's impact.
Primary Ingredients of Cefipark S 500mg/250mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Cefipark S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefipark S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefipark S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefipark S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefipark S 500mg/250mg Injection works:
Cefipark S injection (500mg/250mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Sulbactam counteracts bacterial resistance, thereby bolstering Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cefipark S 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefipark S (500mg/250mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal to no harmful effects on fetal development; nonetheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Cefipark S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefipark S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Operation of a vehicle is contraindicated should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on the administration of Cefipark S 500mg/250mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
The injectable formulation of Cefipark S (500mg/250mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dosage of Cefipark S (500mg/250mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefipark S 500mg/250mg Injection :
Omit a Cefipark S 500mg/250mg Injection dose? Seek your physician's advice.
Facts to Know About Cefipark S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently